2
N-(3-(4-isopropoxyphenyl)prop-2-ynyl)-4-methyl-N-(2-oxo-2H-chromen-6-

yl)benzenesulfonamide: (7c)
Slight 6, 21.9, 42.1, 69.9, 81.4, 86.3, 113.6, 115.6, 117.3, 117.4, 119.1, 128.1, 128.4, 129.5, 131.5, 133.0, 135.3, 135.9, 143.0, 144.0, 153.2, 158.3, 160.3 
N-(3-(2-methoxyphenyl)prop-2-ynyl)-4-methyl-N-(2-oxo-2H-chromen-6-
yl)benzenesulfonamide: (7d)
Hz, 2H), 7.53-7.65 (m, 5H). 13 C NMR (100 MHz, CDCl 3 ): δ C = 21. 5, 42.3, 55.6, 82.9, 87.0, 110.5, 111.2, 117.2, 117.3, 119.0, 120.4, 128.1, 128.5, 129.4, 130.2, 131.8, 133.2, 135.3, 136.0, 143.1, 143.9, 153.2, 160.1, 160.3 . MS: m/z = 460.07 [M+H] + (100 %). Anal. Calcd. for C 26 H 21 NO 5 S: C, 67.96; H, 4.61; N, 3.05 %; found C, 68.07; H, 4.66; N, 3.08 %. 6, 42.1, 68.8, 81.6, 86.1, 114.1, 114.7, 117.2, 117.5, 118.0, 119.1, 128.0, 128.4, 129.5, 131.5, 132.7, 132.9, 135.3, 135.9, 143.1, 144.1, 153.2, 158.9, 160.3 Hz, 1H), 7.87 (d, J = 8.4 Hz, 2H).
N-(3-(4-(benzyloxy)phenyl)prop-2-ynyl)-4-methyl-N-(2-oxo-2H-chromen-6-
13
C NMR (100 MHz, CDCl 3 ): δ C = 21. 6, 26.6, 42.0, 85.3, 86.4, 117.3, 117.5, 119.2, 126.7, 128.0, 128.2, 128.3, 129.6, 131.3, 131.6, 135.2, 135.7, 136.6, 143.0, 144.3, 153.3, 160.2, 197 41.0, 46.1, 55.3, 83.5, 84.1, 111.2, 113.7, 113.9, 114.8, 116.7, 117.4, 119.0, 119.3, 132.3, 133.1, 143.9, 145.1, 146.8, 159.6, 161.5 6, 21.9, 29.6, 42.2, 69.9, 81.7, 86.1, 113.7, 114.8, 115.5, 120.8, 122.4, 128.1, 128.5, 128.6, 129.4, 130.8, 131.9, 132.0, 132.1, 133.0, 133.9, 135.6, 138.7, 139.5, 143.8, 158 
N-(3-(4-ethoxyphenyl)prop-2-ynyl)-4-methyl-N-(1-methyl-2-oxo-1,2-dihydroquinolin-6-
yl)benzenesulfonamide: (7l)
Slight grey 37.5, 42.3, 63.5, 81.8, 86.0, 114.0, 114.4, 114.7, 121.1, 122.5, 128.1, 128.8, 129.4, 130.9, 132.9, 133.7, 135.8, 138.5, 138.6, 143.8, 159.2, 161.7 8, 21.5, 21.6, 37.6, 42.3, 82.7, 86.1, 114.7, 119.0, 121.1, 122.5, 128.1, 128.9, 129.0, 129.4, 130.9, 131.3, 133.6, 135.7, 138.56, 138.65, 138.9, 143.8, 161.7 Compounds 7g, 7h and 7m, 7o, and 7q were prepared according to earlier published procedure.
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General Procedure for the synthesis of pyranoquinoline or phenanthroline derivatives: The alkyne 7 (100 mg) was added to a well-stirred solution of FeCl 3 (1 equiv.) in CH 3 CN (2 mL), at room temperature and the resulting mixture was stirred at 80 o C under nitrogen atmosphere for 12 h. After completion of the reaction (monitored by TLC) the reaction mixture was cooled and extracted with dichloromethane (3 x 25 mL). The combined organic extract was washed with brine (25 mL) and dried over Na 2 SO 4 . The solvent was removed by distillation and the resulting crude residue was purified by filtration through a pad of silica gel (230-400 mesh, PE-EtOAc) to
give the pure cyclized product (9). 8, 21.4, 45.2, 63.5, 114.4, 114.6, 115.3, 117.2, 125.0, 127.5, 128.2, 129.0, 129.3, 130.7, 132.1, 133.7, 136.0, 136.7, 141.4, 143.7, 153.6, 158.7, 160.0 4, 21.4, 45.0, 63.3, 111.8, 114.6, 115.6, 116.5, 120.6, 127.6, 127.8, 128.2, 129.2, 129.3, 129.4, 129.5, 130.2, 133.2, 133.5, 136.8, 141.0, 143.6, 152.9, 155 .0, 160. 114.5, 115.3, 115.8, 117.1, 124.9, 127.5, 128.2, 129.0, 129.3, 130.7, 131.9, 133.7, 136.1, 136.7, 141.4, 143.7, 153.6, 157.7, 159. 70.0, 114.6, 115.0, 115.3, 117.2, 125.1, 127.5, 128.2, 128.7, 128.9, 129.3, 130.7, 132.5, 133.7, 136.0, 136.5, 136.6, 141.3, 143.7, 153.6, 158.5, 159.9 4, 45.2, 68.8, 114.6, 114.7, 115.3, 117.2, 118.1, 125.1, 127.4, 127.5, 128.2, 129.4, 130.1, 130.7, 132.3, 132.9, 133.7, 136.0, 136.6, 141.4, 143.8, 153.6, 158.3, 160.0 3, 22.0, 29.9, 45.3, 70.0, 114.7, 115.6, 117.0, 119.8, 124.7, 127.4, 128.1, 129.0, 129.28, 129.33, 132.2, 132.5, 136.1, 137.1, 137.2, 139.8, 143.5, 157.4, 161.6 8, 21.4, 29.9, 45.3, 63.5, 114.2, 114.7, 116.9, 119.8, 124.7, 127.4, 128.1, 129.0, 129.3, 132.2, 132.7, 136.1, 137.0, 137.2, 139.8, 143.5, 158.5, 161.5 H, 5.39; N, 5.76 %; found C, 69.28; H, 5.45; N, 5 .67 %. C, 68.62; H, 5.12; N, 5.93 %; found C, 68.48; H, 5.15; N, 5 .99 %. 
9-(4-ethoxyphenyl)-7-tosyl-7,8-dihydro-3H-pyrano[3,2-f]quinolin-3-one: (9a)
9-(2-methoxyphenyl)-7-tosyl-7,8-dihydro-3H-pyrano[3,2-f]quinolin-3-one: (9d)
9-(4-(allyloxy)phenyl)-7-tosyl-7,8-dihydro-3H-pyrano[3,2-f]quinolin-3-one: (9f)
Slight
9-(4-methoxyphenyl)-4-methyl-7-tosyl-7,8-dihydro-4,7-phenanthrolin-3(4H)-one: (9i)
9-(4-ethoxyphenyl)-4-ethyl-
